Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Male Hypogonadism Revenue 1.4 Market Analysis by Type 1.4.1 Global Male Hypogonadism Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Testosterone Replacement Therapy 1.4.3 Gonadotropin-Releasing Hormones Therapy 1.5 Market by Application 1.5.1 Global Male Hypogonadism Market Share by Application: 2020 VS 2026 1.5.2 Kallmann Syndrome 1.5.3 Klinefelters Syndrome 1.5.4 Pituitary Disorders 1.5.5 Others 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends by Regions 2.1 Male Hypogonadism Market Perspective (2015-2026) 2.2 Male Hypogonadism Growth Trends by Regions 2.2.1 Male Hypogonadism Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Male Hypogonadism Historic Market Share by Regions (2015-2020) 2.2.3 Male Hypogonadism Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Male Hypogonadism Market Growth Strategy 2.3.6 Primary Interviews with Key Male Hypogonadism Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Male Hypogonadism Players by Market Size 3.1.1 Global Top Male Hypogonadism Players by Revenue (2015-2020) 3.1.2 Global Male Hypogonadism Revenue Market Share by Players (2015-2020) 3.1.3 Global Male Hypogonadism Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Male Hypogonadism Market Concentration Ratio 3.2.1 Global Male Hypogonadism Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Male Hypogonadism Revenue in 2019 3.3 Male Hypogonadism Key Players Head office and Area Served 3.4 Key Players Male Hypogonadism Product Solution and Service 3.5 Date of Enter into Male Hypogonadism Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Male Hypogonadism Historic Market Size by Type (2015-2020) 4.2 Global Male Hypogonadism Forecasted Market Size by Type (2021-2026) 5 Male Hypogonadism Breakdown Data by Application (2015-2026) 5.1 Global Male Hypogonadism Market Size by Application (2015-2020) 5.2 Global Male Hypogonadism Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Male Hypogonadism Market Size (2015-2020) 6.2 Male Hypogonadism Key Players in North America (2019-2020) 6.3 North America Male Hypogonadism Market Size by Type (2015-2020) 6.4 North America Male Hypogonadism Market Size by Application (2015-2020) 7 Europe 7.1 Europe Male Hypogonadism Market Size (2015-2020) 7.2 Male Hypogonadism Key Players in Europe (2019-2020) 7.3 Europe Male Hypogonadism Market Size by Type (2015-2020) 7.4 Europe Male Hypogonadism Market Size by Application (2015-2020) 8 China 8.1 China Male Hypogonadism Market Size (2015-2020) 8.2 Male Hypogonadism Key Players in China (2019-2020) 8.3 China Male Hypogonadism Market Size by Type (2015-2020) 8.4 China Male Hypogonadism Market Size by Application (2015-2020) 9 Japan 9.1 Japan Male Hypogonadism Market Size (2015-2020) 9.2 Male Hypogonadism Key Players in Japan (2019-2020) 9.3 Japan Male Hypogonadism Market Size by Type (2015-2020) 9.4 Japan Male Hypogonadism Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Male Hypogonadism Market Size (2015-2020) 10.2 Male Hypogonadism Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Male Hypogonadism Market Size by Type (2015-2020) 10.4 Southeast Asia Male Hypogonadism Market Size by Application (2015-2020) 11 India 11.1 India Male Hypogonadism Market Size (2015-2020) 11.2 Male Hypogonadism Key Players in India (2019-2020) 11.3 India Male Hypogonadism Market Size by Type (2015-2020) 11.4 India Male Hypogonadism Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Male Hypogonadism Market Size (2015-2020) 12.2 Male Hypogonadism Key Players in Central & South America (2019-2020) 12.3 Central & South America Male Hypogonadism Market Size by Type (2015-2020) 12.4 Central & South America Male Hypogonadism Market Size by Application (2015-2020) 13 Key Players Profiles 13.1 Astrazeneca Plc. 13.1.1 Astrazeneca Plc. Company Details 13.1.2 Astrazeneca Plc. Business Overview and Its Total Revenue 13.1.3 Astrazeneca Plc. Male Hypogonadism Introduction 13.1.4 Astrazeneca Plc. Revenue in Male Hypogonadism Business (2015-2020)) 13.1.5 Astrazeneca Plc. Recent Development 13.2 Merck & Co. Inc. 13.2.1 Merck & Co. Inc. Company Details 13.2.2 Merck & Co. Inc. Business Overview and Its Total Revenue 13.2.3 Merck & Co. Inc. Male Hypogonadism Introduction 13.2.4 Merck & Co. Inc. Revenue in Male Hypogonadism Business (2015-2020) 13.2.5 Merck & Co. Inc. Recent Development 13.3 Laboratories Genevrier 13.3.1 Laboratories Genevrier Company Details 13.3.2 Laboratories Genevrier Business Overview and Its Total Revenue 13.3.3 Laboratories Genevrier Male Hypogonadism Introduction 13.3.4 Laboratories Genevrier Revenue in Male Hypogonadism Business (2015-2020) 13.3.5 Laboratories Genevrier Recent Development 13.4 Allergan Plc. 13.4.1 Allergan Plc. Company Details 13.4.2 Allergan Plc. Business Overview and Its Total Revenue 13.4.3 Allergan Plc. Male Hypogonadism Introduction 13.4.4 Allergan Plc. Revenue in Male Hypogonadism Business (2015-2020) 13.4.5 Allergan Plc. Recent Development 13.5 Endo International Plc. 13.5.1 Endo International Plc. Company Details 13.5.2 Endo International Plc. Business Overview and Its Total Revenue 13.5.3 Endo International Plc. Male Hypogonadism Introduction 13.5.4 Endo International Plc. Revenue in Male Hypogonadism Business (2015-2020) 13.5.5 Endo International Plc. Recent Development 13.6 Ferring 13.6.1 Ferring Company Details 13.6.2 Ferring Business Overview and Its Total Revenue 13.6.3 Ferring Male Hypogonadism Introduction 13.6.4 Ferring Revenue in Male Hypogonadism Business (2015-2020) 13.6.5 Ferring Recent Development 13.7 AbbVie Inc. 13.7.1 AbbVie Inc. Company Details 13.7.2 AbbVie Inc. Business Overview and Its Total Revenue 13.7.3 AbbVie Inc. Male Hypogonadism Introduction 13.7.4 AbbVie Inc. Revenue in Male Hypogonadism Business (2015-2020) 13.7.5 AbbVie Inc. Recent Development 13.8 Eli Lilly and Company Ltd. 13.8.1 Eli Lilly and Company Ltd. Company Details 13.8.2 Eli Lilly and Company Ltd. Business Overview and Its Total Revenue 13.8.3 Eli Lilly and Company Ltd. Male Hypogonadism Introduction 13.8.4 Eli Lilly and Company Ltd. Revenue in Male Hypogonadism Business (2015-2020) 13.8.5 Eli Lilly and Company Ltd. Recent Development 13.9 Finox Biotech 13.9.1 Finox Biotech Company Details 13.9.2 Finox Biotech Business Overview and Its Total Revenue 13.9.3 Finox Biotech Male Hypogonadism Introduction 13.9.4 Finox Biotech Revenue in Male Hypogonadism Business (2015-2020) 13.9.5 Finox Biotech Recent Development 13.10 Teva Pharmaceutical Industries Ltd. 13.10.1 Teva Pharmaceutical Industries Ltd. Company Details 13.10.2 Teva Pharmaceutical Industries Ltd. Business Overview and Its Total Revenue 13.10.3 Teva Pharmaceutical Industries Ltd. Male Hypogonadism Introduction 13.10.4 Teva Pharmaceutical Industries Ltd. Revenue in Male Hypogonadism Business (2015-2020) 13.10.5 Teva Pharmaceutical Industries Ltd. Recent Development 13.11 Bayer AG 10.11.1 Bayer AG Company Details 10.11.2 Bayer AG Business Overview and Its Total Revenue 10.11.3 Bayer AG Male Hypogonadism Introduction 10.11.4 Bayer AG Revenue in Male Hypogonadism Business (2015-2020) 10.11.5 Bayer AG Recent Development 13.12 IBSA Institut Biochimque 10.12.1 IBSA Institut Biochimque Company Details 10.12.2 IBSA Institut Biochimque Business Overview and Its Total Revenue 10.12.3 IBSA Institut Biochimque Male Hypogonadism Introduction 10.12.4 IBSA Institut Biochimque Revenue in Male Hypogonadism Business (2015-2020) 10.12.5 IBSA Institut Biochimque Recent Development 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

List of Tables Table 1. Male Hypogonadism Key Market Segments Table 2. Key Players Covered: Ranking by Male Hypogonadism Revenue Table 3. Ranking of Global Top Male Hypogonadism Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Male Hypogonadism Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Testosterone Replacement Therapy Table 6. Key Players of Gonadotropin-Releasing Hormones Therapy Table 7. Global Male Hypogonadism Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 8. Global Male Hypogonadism Market Size by Regions (US$ Million): 2020 VS 2026 Table 9. Global Male Hypogonadism Market Size by Regions (2015-2020) (US$ Million) Table 10. Global Male Hypogonadism Market Share by Regions (2015-2020) Table 11. Global Male Hypogonadism Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 12. Global Male Hypogonadism Market Share by Regions (2021-2026) Table 13. Market Top Trends Table 14. Key Drivers: Impact Analysis Table 15. Key Challenges Table 16. Male Hypogonadism Market Growth Strategy Table 17. Main Points Interviewed from Key Male Hypogonadism Players Table 18. Global Male Hypogonadism Revenue by Players (2015-2020) (Million US$) Table 19. Global Male Hypogonadism Market Share by Players (2015-2020) Table 20. Global Top Male Hypogonadism Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Male Hypogonadism as of 2019) Table 21. Global Male Hypogonadism by Players Market Concentration Ratio (CR5 and HHI) Table 22. Key Players Headquarters and Area Served Table 23. Key Players Male Hypogonadism Product Solution and Service Table 24. Date of Enter into Male Hypogonadism Market Table 25. Mergers & Acquisitions, Expansion Plans Table 26. Global Male Hypogonadism Market Size by Type (2015-2020) (Million US$) Table 27. Global Male Hypogonadism Market Size Share by Type (2015-2020) Table 28. Global Male Hypogonadism Revenue Market Share by Type (2021-2026) Table 29. Global Male Hypogonadism Market Size Share by Application (2015-2020) Table 30. Global Male Hypogonadism Market Size by Application (2015-2020) (Million US$) Table 31. Global Male Hypogonadism Market Size Share by Application (2021-2026) Table 32. North America Key Players Male Hypogonadism Revenue (2019-2020) (Million US$) Table 33. North America Key Players Male Hypogonadism Market Share (2019-2020) Table 34. North America Male Hypogonadism Market Size by Type (2015-2020) (Million US$) Table 35. North America Male Hypogonadism Market Share by Type (2015-2020) Table 36. North America Male Hypogonadism Market Size by Application (2015-2020) (Million US$) Table 37. North America Male Hypogonadism Market Share by Application (2015-2020) Table 38. Europe Key Players Male Hypogonadism Revenue (2019-2020) (Million US$) Table 39. Europe Key Players Male Hypogonadism Market Share (2019-2020) Table 40. Europe Male Hypogonadism Market Size by Type (2015-2020) (Million US$) Table 41. Europe Male Hypogonadism Market Share by Type (2015-2020) Table 42. Europe Male Hypogonadism Market Size by Application (2015-2020) (Million US$) Table 43. Europe Male Hypogonadism Market Share by Application (2015-2020) Table 44. China Key Players Male Hypogonadism Revenue (2019-2020) (Million US$) Table 45. China Key Players Male Hypogonadism Market Share (2019-2020) Table 46. China Male Hypogonadism Market Size by Type (2015-2020) (Million US$) Table 47. China Male Hypogonadism Market Share by Type (2015-2020) Table 48. China Male Hypogonadism Market Size by Application (2015-2020) (Million US$) Table 49. China Male Hypogonadism Market Share by Application (2015-2020) Table 50. Japan Key Players Male Hypogonadism Revenue (2019-2020) (Million US$) Table 51. Japan Key Players Male Hypogonadism Market Share (2019-2020) Table 52. Japan Male Hypogonadism Market Size by Type (2015-2020) (Million US$) Table 53. Japan Male Hypogonadism Market Share by Type (2015-2020) Table 54. Japan Male Hypogonadism Market Size by Application (2015-2020) (Million US$) Table 55. Japan Male Hypogonadism Market Share by Application (2015-2020) Table 56. Southeast Asia Key Players Male Hypogonadism Revenue (2019-2020) (Million US$) Table 57. Southeast Asia Key Players Male Hypogonadism Market Share (2019-2020) Table 58. Southeast Asia Male Hypogonadism Market Size by Type (2015-2020) (Million US$) Table 59. Southeast Asia Male Hypogonadism Market Share by Type (2015-2020) Table 60. Southeast Asia Male Hypogonadism Market Size by Application (2015-2020) (Million US$) Table 61. Southeast Asia Male Hypogonadism Market Share by Application (2015-2020) Table 62. India Key Players Male Hypogonadism Revenue (2019-2020) (Million US$) Table 63. India Key Players Male Hypogonadism Market Share (2019-2020) Table 64. India Male Hypogonadism Market Size by Type (2015-2020) (Million US$) Table 65. India Male Hypogonadism Market Share by Type (2015-2020) Table 66. India Male Hypogonadism Market Size by Application (2015-2020) (Million US$) Table 67. India Male Hypogonadism Market Share by Application (2015-2020) Table 68. Central & South America Key Players Male Hypogonadism Revenue (2019-2020) (Million US$) Table 69. Central & South America Key Players Male Hypogonadism Market Share (2019-2020) Table 70. Central & South America Male Hypogonadism Market Size by Type (2015-2020) (Million US$) Table 71. Central & South America Male Hypogonadism Market Share by Type (2015-2020) Table 72. Central & South America Male Hypogonadism Market Size by Application (2015-2020) (Million US$) Table 73. Central & South America Male Hypogonadism Market Share by Application (2015-2020) Table 74. Astrazeneca Plc. Company Details Table 75. Astrazeneca Plc. Business Overview Table 76. Astrazeneca Plc. Product Table 77. Astrazeneca Plc. Revenue in Male Hypogonadism Business (2015-2020) (Million US$) Table 78. Astrazeneca Plc. Recent Development Table 79. Merck & Co. Inc. Company Details Table 80. Merck & Co. Inc. Business Overview Table 81. Merck & Co. Inc. Product Table 82. Merck & Co. Inc. Revenue in Male Hypogonadism Business (2015-2020) (Million US$) Table 83. Merck & Co. Inc. Recent Development Table 84. Laboratories Genevrier Company Details Table 85. Laboratories Genevrier Business Overview Table 86. Laboratories Genevrier Product Table 87. Laboratories Genevrier Revenue in Male Hypogonadism Business (2015-2020) (Million US$) Table 88. Laboratories Genevrier Recent Development Table 89. Allergan Plc. Company Details Table 90. Allergan Plc. Business Overview Table 91. Allergan Plc. Product Table 92. Allergan Plc. Revenue in Male Hypogonadism Business (2015-2020) (Million US$) Table 93. Allergan Plc. Recent Development Table 94. Endo International Plc. Company Details Table 95. Endo International Plc. Business Overview Table 96. Endo International Plc. Product Table 97. Endo International Plc. Revenue in Male Hypogonadism Business (2015-2020) (Million US$) Table 98. Endo International Plc. Recent Development Table 99. Ferring Company Details Table 100. Ferring Business Overview Table 101. Ferring Product Table 102. Ferring Revenue in Male Hypogonadism Business (2015-2020) (Million US$) Table 103. Ferring Recent Development Table 104. AbbVie Inc. Company Details Table 105. AbbVie Inc. Business Overview Table 106. AbbVie Inc. Product Table 107. AbbVie Inc. Revenue in Male Hypogonadism Business (2015-2020) (Million US$) Table 108. AbbVie Inc. Recent Development Table 109. Eli Lilly and Company Ltd. Business Overview Table 110. Eli Lilly and Company Ltd. Product Table 111. Eli Lilly and Company Ltd. Company Details Table 112. Eli Lilly and Company Ltd. Revenue in Male Hypogonadism Business (2015-2020) (Million US$) Table 113. Eli Lilly and Company Ltd. Recent Development Table 114. Finox Biotech Company Details Table 115. Finox Biotech Business Overview Table 116. Finox Biotech Product Table 117. Finox Biotech Revenue in Male Hypogonadism Business (2015-2020) (Million US$) Table 118. Finox Biotech Recent Development Table 119. Teva Pharmaceutical Industries Ltd. Company Details Table 120. Teva Pharmaceutical Industries Ltd. Business Overview Table 121. Teva Pharmaceutical Industries Ltd. Product Table 122. Teva Pharmaceutical Industries Ltd. Revenue in Male Hypogonadism Business (2015-2020) (Million US$) Table 123. Teva Pharmaceutical Industries Ltd. Recent Development Table 124. Bayer AG Company Details Table 125. Bayer AG Business Overview Table 126. Bayer AG Product Table 127. Bayer AG Revenue in Male Hypogonadism Business (2015-2020) (Million US$) Table 128. Bayer AG Recent Development Table 129. IBSA Institut Biochimque Company Details Table 130. IBSA Institut Biochimque Business Overview Table 131. IBSA Institut Biochimque Product Table 132. IBSA Institut Biochimque Revenue in Male Hypogonadism Business (2015-2020) (Million US$) Table 133. IBSA Institut Biochimque Recent Development Table 134. Research Programs/Design for This Report Table 135. Key Data Information from Secondary Sources Table 136. Key Data Information from Primary Sources List of Figures Figure 1. Global Male Hypogonadism Market Share by Type: 2020 VS 2026 Figure 2. Testosterone Replacement Therapy Features Figure 3. Gonadotropin-Releasing Hormones Therapy Features Figure 4. Global Male Hypogonadism Market Share by Application: 2020 VS 2026 Figure 5. Kallmann Syndrome Case Studies Figure 6. Klinefelters Syndrome Case Studies Figure 7. Pituitary Disorders Case Studies Figure 8. Others Case Studies Figure 9. Male Hypogonadism Report Years Considered Figure 10. Global Male Hypogonadism Market Size YoY Growth 2015-2026 (US$ Million) Figure 11. Global Male Hypogonadism Market Share by Regions: 2020 VS 2026 Figure 12. Global Male Hypogonadism Market Share by Regions (2021-2026) Figure 13. Porter's Five Forces Analysis Figure 14. Global Male Hypogonadism Market Share by Players in 2019 Figure 15. Global Top Male Hypogonadism Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Male Hypogonadism as of 2019 Figure 16. The Top 10 and 5 Players Market Share by Male Hypogonadism Revenue in 2019 Figure 17. North America Male Hypogonadism Market Size YoY Growth (2015-2020) (Million US$) Figure 18. Europe Male Hypogonadism Market Size YoY Growth (2015-2020) (Million US$) Figure 19. China Male Hypogonadism Market Size YoY Growth (2015-2020) (Million US$) Figure 20. Japan Male Hypogonadism Market Size YoY Growth (2015-2020) (Million US$) Figure 21. Southeast Asia Male Hypogonadism Market Size YoY Growth (2015-2020) (Million US$) Figure 22. India Male Hypogonadism Market Size YoY Growth (2015-2020) (Million US$) Figure 23. Central & South America Male Hypogonadism Market Size YoY Growth (2015-2020) (Million US$) Figure 24. Astrazeneca Plc. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 25. Astrazeneca Plc. Revenue Growth Rate in Male Hypogonadism Business (2015-2020) Figure 26. Merck & Co. Inc. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 27. Merck & Co. Inc. Revenue Growth Rate in Male Hypogonadism Business (2015-2020) Figure 28. Laboratories Genevrier Total Revenue (US$ Million): 2019 Compared with 2018 Figure 29. Laboratories Genevrier Revenue Growth Rate in Male Hypogonadism Business (2015-2020) Figure 30. Allergan Plc. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 31. Allergan Plc. Revenue Growth Rate in Male Hypogonadism Business (2015-2020) Figure 32. Endo International Plc. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 33. Endo International Plc. Revenue Growth Rate in Male Hypogonadism Business (2015-2020) Figure 34. Ferring Total Revenue (US$ Million): 2019 Compared with 2018 Figure 35. Ferring Revenue Growth Rate in Male Hypogonadism Business (2015-2020) Figure 36. AbbVie Inc. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 37. AbbVie Inc. Revenue Growth Rate in Male Hypogonadism Business (2015-2020) Figure 38. Eli Lilly and Company Ltd. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 39. Eli Lilly and Company Ltd. Revenue Growth Rate in Male Hypogonadism Business (2015-2020) Figure 40. Finox Biotech Total Revenue (US$ Million): 2019 Compared with 2018 Figure 41. Finox Biotech Revenue Growth Rate in Male Hypogonadism Business (2015-2020) Figure 42. Teva Pharmaceutical Industries Ltd. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 43. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Male Hypogonadism Business (2015-2020) Figure 44. Bayer AG Total Revenue (US$ Million): 2019 Compared with 2018 Figure 45. Bayer AG Revenue Growth Rate in Male Hypogonadism Business (2015-2020) Figure 46. IBSA Institut Biochimque Total Revenue (US$ Million): 2019 Compared with 2018 Figure 47. IBSA Institut Biochimque Revenue Growth Rate in Male Hypogonadism Business (2015-2020) Figure 48. Bottom-up and Top-down Approaches for This Report Figure 49. Data Triangulation Figure 50. Key Executives Interviewed

Astrazeneca Plc. Merck & Co. Inc. Laboratories Genevrier Allergan Plc. Endo International Plc. Ferring AbbVie Inc. Eli Lilly and Company Ltd. Finox Biotech Teva Pharmaceutical Industries Ltd. Bayer AG IBSA Institut Biochimque